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INTRODUCTION
Endometriosis is a gynecologic disorder commonly
affecting females during their reproductive age. The
prevalence is estimated as high as 4% of all females
in reproductive age. Endometriosis could also be
found in 20-40% of females who came for infertility
problems.(1-4) Even though endometriosis was already
founded in the early of 17th century, but until now
what is the actual etiology and pathogenesis of en-
dometriosis still become a big enigma.(5,6)
Endometriosis is a gynecologic disorder charac-
terized by the growth of endometrial tissue outside of
the uterus (ectopic endometrium).(7) In 1927, Samp-
son introduced an idea about the possible origin of
endometriosis lesion probably coming from endo-
metrial sheding inside uterine cavity during menstrua-
tion. Menstrual blood consists of endometrial tissue
could flow backward to the abdominal cavity, instead
of flow out normally through the vaginal canal (retro-
grade menstruation).(8) Cells that contains inside the
menstrual blood shows good capability to survive in-
side a peritoneal cavity.(9,10) 76% of females with
patent tubes under laparoscopic observation shows re-
gurgitation of menstrual blood to peritoneal cavity.(11)
However, not all female with menstrual regurgitation
will suffer pelvic endometriosis.(12) There should be
Abstract
Objectives: To observe the distribution of Regulatory T-cell
(CD4+, CD25+) in the peritoneal fluid of endometriosis patients, as
related to the local immune system of the peritoneum.
Method: A cross-sectional descriptive research Perioneal fluid
was taken from endometriosis patients and non-endometriosis pa-
tients who underwent laparoscopic or laparotomy surgery at Raden
Saleh Reproductive Health Clinic and Central Operating Theatre be-
tween June 2008 to March 2009. Total leukocyte and its differential
count was counted manually. Regulatory T-cell was labelled with
monoclonal antibodies for CD45 (PerCP-347464), CD4 (SIPC-
340133) dan CD25 (PE-341009) and counted by Flowcytometry
(Facscalibur) using cellquest pro software. Data were collected and
analyzed with SPSS ver 11 software.
Result: Thirty-three patients were participated in this study, 12
non-endometriosis and 21 endometriosis patients were analyzed. 10
endometriosis patients were classified as minimal-mild, while 11
others were in moderate-severe stage. Higher median level of Regu-
latory T-cells were found in endometriosis patients (0.52%) com-
pared to non-endometriosis cases (0.12%), even it was not signifi-
cantly different (p 0.403). The median level of Regulatory T-cell in
minimal-mild endometriosis (0.46%) was not significantly different
with moderate severe endometriosis (0.52%) (p 0.981).
Conclusion: The percentage and total number of Regulatory T-
cell in the peritoneal fluid did not show significant difference be-
tween endometriosis and non-endometriosis patients. Endometriosis
patients shows tendency of higher percentage and total number of
Regulatory T-cell than non-endometriosis group. The stage of en-
dometriosis apparently does not show any significant difference in
terms of Regulatory T-cell in peritoneal fluid.
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Abstrak
Tujuan: Untuk mengetahui sebaran kadar sel T Regulator
(CD4+, CD25+) cairan peritoneum pada kasus endometriosis ter-
kait dengan sistem imun lokal di peritoneum.
Metode: Penelitian ini bersifat deskriptif potong lintang. Kasus
endometriosis yang datang ke klinik Kesehatan Reproduksi Raden
Saleh RSUPNCM dan dilakukan laparoskopi Juni 2008 sampai de-
ngan Maret 2009 dimasukkan sebagai sampel sebagai kontrol diam-
bil kasus non endometriosis yang dilakukan laparoskopi maupun la-
parotomi di Klinik kesehatan Reproduksi Raden Saleh dan OK sen-
tral RSUPNCM.
Hasil: Didapatkan 33 sediaan yang terdiri dari 12 kasus non en-
dometriosis dan 21 kasus endometriosis. Didapatkan kecenderun-
gan lebih tingginya kadar Treg maupun jumlah total Treg pada kasus
endometriosis dibandingkan non endometriosis. Hal ini sesuai de-
ngan asumsi bahwa peningkatan sel T regulator dapat menginhibisi
sifat sitotoksik dari limfosit T sitotoksik dan sel NK melalui meka-
nisme langsung dari sel ke sel. Meski demikian secara statistik tidak
didapatkan perbedaan yang bermakna pada kedua kelompok. Dera-
jat endometriosis ternyata tidak menunjukkan perbedaan yang ber-
makna terhadap pola sebaran Treg.
Kesimpulan: Sebaran kadar sel T regulator dalam cairan peri-
toneum penderita endometriosis dan non endometriosis tidak me-
nunjukkan perbedaan bermakna secara statistik, namun pada ke-
lompok kasus menunjukkan kecenderungan nilai yang lebih tinggi
dibandingkan pada kasus nonendometriosis.
[Maj Obstet Ginekol Indones 2010; 34-1:19-23]
Kata kunci: sel T regulator, CD4 CD 25, cairan peritoneum, en-
dometriosis
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contributions from other local factor that finally could
trigger endometriosis condition. One factor that con-
sidered has a potential role in the pathogenesis of en-
dometriosis is the characteristics of immune system
in the peritoneal cavity which normally should pre-
vent the implantation and growth of the endometrial
tissue.(13)
Previous studies have discovered the role of T
helper 1/T helper 2 (Th1/Th2) in endometriosis.(14)
Th1 and Th2 cells are a subset of T helper lymphocyte
and has an ability to release certain cytokines. Th1
cytokines release will induce cellular immunity, while
Th2 on the contrary will induce humoral immunity.
The immune system responses are mainly regulated
by the presence of another T lymphocyte subset called
regulatory T cells (Treg). The important role of Treg
is to maintain the balance between Th1 and Th2 to
assure adequate and proper immune response. Cur-
rently, there are many researches are trying to study
the role of Treg cells to prevent the incidence of trans-
plantation tissue rejection, autoimmune reaction, and
immune responses in general.(15,16) Since endo-
metriosis tissue survival in peritoneal cavity is very
obvious, the question regarding to the role of local
immune system in the pelvic cavity become more in-
teresting. Treg has been known to have abilities in
regulating immune response by either through direct
cell to cell contact or by releasing certain kind of cy-
tokines. Therefore, the idea of the role of Treg in en-
dometriosis development could become a possibility.
There were many hypothesis and studies also trying
to describe how the local immune system in the pelvic
cavity reacts to the presence of endometriosis les-
sions. However, there are two possibilities that could
explain why the local immune system do not react
properly to endometriosis lessions. Low immune re-
sponse in pelvic cavity could be induced by sub-
stances released from the endometriosis tissue, or the
local immune system itself could not react properly.
This study basically would like to observe the role
of Treg in regulating the local immune system. First
basic thought about the possible role of Treg on this
circumstances is a high amount of Treg cell possibly
could inhibit the cytotoxic activities of CD8+ and NK
cells. There was a study showing the changes of Natu-
ral Killer (NK) cell.(17) On the contrary, if the number
of Treg is low it might also contribute to the process
of tissue destruction by the inability to regulate proper
immune response of T lymphocyte. Uncontrolled T T
helper lymphocyte could induce particular cytokines
release that could be used as supporting factors for
endometriosis growth and development.
METHODOLOGY
The design of this research is an observational study
consisting of several cross sectional studies. A cross
sectional study held on February 2008 until March
2009 in the IBS operating chamber and the Raden
Saleh Reproductive Health Clinic and Makmal En-
dokrinologi FKUI-RSUPNCM, Jakarta. This is an ob-
servational study. Data and specimen were taken in
cross sectional fashion.
The study was done from February 2008 to March
2009. Patients who underwent laparotomy or laparo-
scopy for endometriosis or other gynecology prob-
lems at the Central Operating Theatre (COT) or
Raden Saleh Clinic at Dr Cipto Mangunkusumo Gen-
eral Hospital, Jakarta and match with the inclusion
criteria were asked to participate in the study. Perito-
neal fluid was taken from each patient and sent to
Makmal Laboratory Faculty of medicine University
of Indonesia for further analysis. Number of Treg cell
was counted using Facscalibur machine using CD45
(PerCP-347464), CD4 (SIPC-340133) and CD25 (PE-
341009) markers. Treg cells was counted using
cellquest pro software. Data were collected and ana-
lyzed with SPSS ver. 11 software. Each quantitative
variable was calculated for mean and standard devia-
tion. Correlation between two quantitative variables
was measured with Pearson method for normal dis-
tributed data. On the other hand if data was not nor-
mally distributed the correlation between two vari-
ables was analyzed by Spearman method. Correlations
between qualitative or quantitative variables were
analyzed by t-test or chi square for normally distrib-
uted data and Mann Whitney or Kruskal Wallis if data
was not normally distributed.
Table 1. Distribution of regulatory T cells
Variable
Non endometriosis (n=12) Endometriosis (n=22)
p
Mean SD Median Mean SD Median
Content Treg 1.864 4.903 0.115 5.429 14.016 0.520 0.403
Total Treg 2.114 6.427 0.000 415.698 1618.480 3.864 0.386
Info: p is considered significant if <0,05
To observe whether is there any difference in terms
of Treg level based on the severity of endometriosis,
endometriosis group was divided into minimal-mild
endometriosis and moderate-severe endometriosis ac-
cording to the criteria from American Fertility Society
(AFS). The median for Treg precentages in minimal-
mild endometriosis group (0.455) and in moderate-
severe endometriosis group (0.520), do not show sig-
nificant difference (p 0.981). Moreover, The median
for total number of Treg in minimal-mild endo-
metriosis group (1.987), and in moderate-severe en-
dometriosis group (11.448), also do not show signifi-
cant difference (p 0.291).
Table 2. Distribution of Regulatory T cells in endometriosis group
Variable
Mild-moderate
endometriosis
(n=10)
Severe
Endometriosis
(n=11) p
Mean SD Median Mean SD Median
Content Treg 5.35 13.828 0.455 5.50 14.85 0.520 0.981
Total Treg 14.966 32.714 1.987 779.85 2220.706 11.448 0.291
Information: p is considered significant if <0,05
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In the initial phase of the study, gating was done
to take lymphocyte cells from the acquired leukocyte
population (side scatter and CD45), while gating from
the flowcytometry result shows that there is still no
uniformity in deciding the limit of Treg content. Uni-
formity in gating decision is achieved after several
gating attempts.
DISCUSSIONS
From thirty three patients who is participating in this
study 63.6% of them were diagnosed as endome-
triosis. These finding is consistent with previous stud-
ies that state endometriosis is involved in as much as
68% cases of infertility.(18)
There are several factors involved in the patho-
genesis of endometriosis, including hormonal factors,
environmental factors, excessive retrograde menstrua-
tion because of obstruction, and local immune system
disruption in the pelvic cavity.
Sampson argued that endometriosis is derived from
the implantation of cells found in menstrual fluid that
spilled into the abdominal cavity. The viability of
cells contains in the menstrual blood and their ability
to implant and grow in the peritoneal cavity has been
showed in previous studies.(9,10) 76% of women with
patent fallopian tubes proved by laparoscopic obser-
vation shows menstrual blood registration that could
induce pelvic endometriosis.(11) However, approxi-
mately only 10% of women who experience menstrual
blood regurgitation might suffer endometriosis.(12)
That means, some factors could play essential roles
in the pathogenesis of pelvic endometriosis. Some hy-
pothesis were saying about the possible role of the
significant amount of menstrual blood regurgitated
into the abdominal cavity. Moreover, there were also
studies which try to describe the possible immune sys-
tem disruption in the pelvic cavity, thus the cleaning
mechanisms cannot working properly. The inability
of pelvic immune system to clean the regurgitated
menstrual blood loss could trigger the possibility of
endometrial tissue implantation and growth in the pel-
vic cavity. Recent studies also shows some unsatis-
factory result from either surgical or medical treat-
ment in some particular endometriosis cases. This is
often showed by the incidence of recurrency in par-
ticular endometriosis cases.(19) Therefore, the current
alternative treatment for endometriosis that has been
strongly considered so far is to modulate the immune
response to endometriosis. Initial study has shown the
changes in terms of quantity and activity of the leu-
kocyte population in endometriosis patients. More-
over, the dysfunction of killing activity of the Natural
Killer (NK) cell and macrophages in endometriosis
patients also has been detected already.
These findings has been considered as an indica-
tion of immune response failure to endometriosis in
the pelvic cavity.(10, 25) the failure of immune system
to give adequate response to particular agents could
reflect a possible disruption in immune regulation.
Human immune system has been designed to react
adequately and properly to each agents in order to
prevent the human body from harmful agents. On the
other hand the human immune system should also
regulated not to induce harmful immune reactions to
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Picture 1. Lymphocyte gating from the leukocyte population
distribution based on side scatter and CD45
10
0
10
1
10
2
10
3
10
4
C
D
25
 P
E
CD4 FITC
102101100 103 104
CD4  CD25   Kasus Endometriosis+ +
6%
0.25%
4.29%64.92%
30.54%
Picture 2. Gating of Treg CD4+ CD25+ content in
non-endometriosis and endometriosis cases
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its’ body. The regulation of human immune system
is complex and involving particular immune cells and
its’ substances. One of the prominent immune regu-
lator cell in human immune system is a subpopulation
of T Lymphocyte called Regulatory T cell (Treg). Pre-
vious studies shows this cell carry a specific markers
on its’ surface (CD4+CD25+) and plays an important
role in peripheral tolerance, immune regulation and
transplantation reaction. Since regurgitated menstrual
blood coud be considered as a transplant tissue that
is trying to reach the peritoneal layer, thus the im-
mune response reaction from the pelvic cavity could
decide the final result from this reaction. Based on
this thought, Treg possibly play an essential role in
the implantation and growth of the endometriosis tis-
sue in the pelvic cavity by regulating local immune
response to regurgitated endometrial tissue. One study
shows the ability of Treg in preventing the occurrence
of graft rejection during transplantation by suppress-
ing T Lymphocyte response.(26)
This study shows either the percentage and the to-
tal number of Treg is higher in endometriosis group,
eventhough the difference is not statistically signifi-
cant. However, through this finding we might expect
the presence of Treg in relative higher number in en-
dometriosis patients could be associated with the pos-
sibility of its’ role in inhibiting killing or cytotoxic
activities from the Cytotoxic T Lymphocyte (CTL)
and NK cell. Thus, defect in the killing activity of
local CTL and NK cell in pelvic cavity could facilitate
the implantation and subsequent growth of the endo-
metriosis tissues.
This study was also trying to observe the correla-
tion between the presence of Treg and the severity of
endometriosis. There is a tendency of higher Treg per-
centage and total number in moderate severe en-
dometriosis compared to minimal-mild endometriosis.
However, the difference between two groups unfor-
tunately is not statistically significant. This finding
also shows early indication regarding the hypothesis
of possible immune defects in the pelvic cavity.
However, previous study that has been conducted
by Tariverdian etal in 2009 shows an opposite results.
He found a lower Treg in endometriosis group. There-
fore, there is some conflicting results compared to the
previous study. In order to answer that issue, a more
detail study to observe the real interaction between
immune cells in the pelvic cavity is required. This
study could only shown the tendency in terms of per-
centage and total number of Treg. How Treg could in-
fluence the other local immune cells in pelvic cavity
still become a question. It was realized since the be-
ginning that studying a local immune response is
more difficult since it could not be representated by
the peripheral cells or substances. Therefore, the pro-
cedure to collect the local specimen could become a
factor that might influence the result.
CONCLUSION
There is no difference in terms of Treg percentage or
total number in pelvic cavity between endometriosis
and non-endometriosis patients. There is no difference
according to Treg between minimal-mild endome-
triosis and moderate severe endometriosis.
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